NEW
YORK, June 24, 2024 /PRNewswire/ -- The
global flow diversion aneurysm treatment market size is
estimated to grow by USD
2.43 billion from 2024-2028, according to Technavio.
The market is estimated to grow at a CAGR of 9.34%
during the forecast period. The flow diversion aneurysm
treatment market is booming due to the rising prevalence of
intracranial aneurysms and the growing popularity of minimally
invasive treatments.
Research report provides comprehensive data on impact of trend.
For more details- Download a Sample Report
Here's a quick breakdown of the key drivers and challenges in
this market:
Market Drivers:
- Increasing awareness and diagnosis of intracranial
aneurysms: More people are being diagnosed with aneurysms,
thanks to better imaging techniques and public health
campaigns.
- Minimally invasive nature of flow diversion
procedures: Compared to traditional brain surgery, flow
diversion offers a less risky and quicker recovery time for
patients.
- Improved patient outcomes: Flow diverters
effectively redirect blood flow away from the aneurysm, promoting
clot formation and preventing rupture.
Market Challenges:
- Stringent regulatory hurdles: Getting flow diverter
devices approved by regulatory bodies like the FDA can be a lengthy
and expensive process.
- High cost of treatment: Flow diversion procedures
can be expensive, limiting access for some patients. Lack of proper
reimbursement policies in certain regions further restricts
affordability.
- Procedural complexity: Flow diversion requires highly
skilled surgeons and specialized equipment, which may not be
readily available in all hospitals.
Market Players and Products:
Major players in this market include companies like Stryker,
Medtronic, and MicroVention who develop and manufacture flow
diverter devices. These devices come in various types, with FDS
(Flow Diversion Stents) being the most common.
Market Outlook:
Despite the challenges, the flow diversion aneurysm treatment
market is expected to continue growing due to rising patient
demand, technological advancements, and increasing awareness about
this minimally invasive treatment option.
About Technavio
Technavio is a leading global technology research and advisory
company. Their research and analysis focuses on emerging market
trends and provides actionable insights to help businesses identify
market opportunities and develop effective strategies to optimize
their market positions.
With over 500 specialized analysts, Technavio's report library
consists of more than 17,000 reports and counting, covering 800
technologies, spanning across 50 countries. Their client base
consists of enterprises of all sizes, including more than 100
Fortune 500 companies. This growing client base relies on
Technavio's comprehensive coverage, extensive research, and
actionable market insights to identify opportunities in existing
and potential markets and assess their competitive positions within
changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
View original content to download
multimedia:https://www.prnewswire.com/news-releases/flow-diversion-aneurysm-treatment-market-size-is-set-to-grow-by-usd-2-43-billion-from-2024-2028--increasing-incidence-of-intracranial-aneurysms-boost-the-market-technavio-302179819.html
SOURCE Technavio